NOTE 5 – INTANGIBLE ASSETS AND GOODWILL

 

Intangible assets, net consists of the following (in thousands):

 

   December 31, 2024   December 31, 2023 
   Gross Carrying Amount   Accumulated Amortization   Net   Gross Carrying Amount   Accumulated Amortization   Net 
In-process research and development  $2,900,000   $
-
   $2,900,000   $2,900,000   $
-
   $2,900,000 
Patents and intellectual property   5,671,478    (1,260,328)   4,411,150    5,671,478    (630,164)   5,041,314 
Intangible assets, net  $8,571,478   $(1,260,328)  $7,311,150   $8,571,478   $(630,164)  $7,941,314 

 

As of December 31, 2024, future expected amortization expense of Intangible assets was as follows:

 

2025   630,164 
2026   630,164 
2027   630,164 
2028   630,164 
2029   630,164 
Thereafter   1,260,329 
Remaining future amortization expense  $4,411,150 

 

There were no changes to goodwill for the year ended December 31, 2024 and 2023, respectively.

Free Sentinel

Want the next Pasithea Therapeutics Corp. goodwill & intangibles disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment Pasithea Therapeutics Corp.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

About Goodwill & Intangibles Disclosures

Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.

Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.